scispace - formally typeset
C

Carrie Fitzpatrick

Researcher at University of Chicago

Publications -  33
Citations -  1725

Carrie Fitzpatrick is an academic researcher from University of Chicago. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 27 publications receiving 1344 citations. Previous affiliations of Carrie Fitzpatrick include University of Illinois at Chicago.

Papers
More filters
Journal ArticleDOI

Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma

TL;DR: Sundar et al. as mentioned in this paper used multiregion sequencing to evaluate genomic heterogeneity in Gastroesophageal adenocarcinoma (GEA) and found that genomic biomarkers were recurrently discrepant between the primary tumor and untreated metastases.
Journal ArticleDOI

Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations

TL;DR: Afatinib demonstrated significant activity in patients with platinum-refractory UC with HER2 or ERBB3 alterations and deserves further investigation in molecularly selected UC.
Journal ArticleDOI

Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays

TL;DR: The clinical validation of 76 genes from a novel 1212-gene large-scale hybrid capture cancer sequencing assay is presented using full-data comparisons against multiple clinical NGS amplicon-based assays to yield dramatic increases in per-sample data comparison efficiency compared with previously published validations.
Journal ArticleDOI

Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL.

TL;DR: In patients who had Richter transformation, it is found that the transformed cells were clonal descendants of circulating leukemia cells but continued to undergo evolution and drifts, and transformed lymphoma cells in tissue may acquire a different BTK mutation from that in the CLL leukemia cells.